Overview Of Baltia

New Post Public Reply Private Reply Replies (0) Message Board
speckulater The Lieutenant #1016
Overview Of Baltia Airlines















ITEM 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations





OVERVIEW






Baltia Air Lines, Inc. the “Company” or “Baltia” or “Baltia Air Lines”) is the only Part 121 (heavy jet operator) start-up airline in the United States today that has received Government fitness approval. The Company is currently in the second phase of the FAA Air Carrier Certification. The Company is a New York State corporation, organized in the State of New York on August 24, 1989.


On December 19, 2008, the U.S. Department of Transportation (DOT) issued its Order to Show Cause, finding that the Company is fit, willing and able to engage in international air transport of persons, property and mail. The Company was awarded the non-stop route from JFK to St. Petersburg Russia. Baltia was also authorized for worldwide charter services.


On August 18, 2009, the Company purchased Boeing 747 aircraft (N705BL). In 2010 the Company purchased a second Boeing 747 aircraft (N706BL). The Company leased engines on a power-by-the-hour basis, which are installed on the aircraft. On January 11, 2012 the Company sold Boeing 747 aircraft (N705BL).


In the third quarter of 2012, the Company opened an office in Ypsilanti, Michigan, where flights crews will undergo flight training. Also, at this location, major aircraft maintenance will be completed on a contract basis by an aircraft maintenance contractor. This location will also serve as the Company’s flight operations center.


The Company currently carries $100,000,000 aircraft liability insurance, and has placed $10 million airline liability insurance through Aviation Risk Management Associates meeting the regulatory requirement in preparation for the commencement of revenue operations.


Following the commencement of service on the JFK-St. Petersburg route, the Company’s objective is to develop its route network to Russia, Latvia, Ukraine, and Belarus.


We intend to provide full service, i.e. passenger, cargo and mail, and will not be dependent upon one or a few major customers. The Company has two registered trademarks "BALTIA" and "VOYAGER CLASS" and five trademarks are subject to registration.


There is currently no non-stop service from JFK to St. Petersburg. Connecting service is provided mainly by foreign carriers. Finnair, Lufthansa and SAS are the leading competitors in the US-Russia market. KLM, British Airways, Air France, Austrian Airlines, and Swissair also provide service. However, foreign carriers are required to have intermediate stops at transit airports in their respective countries (Helsinki, Frankfurt, Stockholm, Copenhagen, etc.) because they are “third nation” airlines and as such cannot fly directly between the US and Russia (only a US airline as well as a reciprocating Russian airline is eligible to fly nonstop). Delta and two Russian airlines, Aeroflot and Transaero, currently operate between JFK and Moscow. With the exception of the JFK-Moscow route, there is no other non-stop competitive air transportation service on the routes for which the Company intends to apply.


The Company’s objective is to establish itself as the leading non-stop carrier in the market niche over the North Atlantic with operations that are profitable and growing over time. In order to accomplish this objective, we intend to establish and maintain high quality service standards which we believe will be competitive with the European airlines currently providing connecting flights. The Company does not expect to be in direct competition with deep discount airlines, including several East European airlines and the offspring of the former Soviet airline Aeroflot, which provide connecting flights.


The Company intends to provide First, Business, and Voyager Class accommodations. The Company’s passenger market strategy is tailored to particular preferences of the various segments of its customer base, with marketing attention particularly focused on American business travelers with interests in Russia who require high quality, non-stop service from the United States to Russia.


The Company’s initial marketing strategy is based on existing agencies specializing in the market, selected travel and business publications, supplemented by direct mailings to corporate travel planners, and individual American businesses that are currently involved in Russia. Soon after the inauguration of flight service, the Company plans to implement its frequent flyer program. As the marketing matures, the Company plans to advertise to the general public throughout the US, and in Russia. The Company also plans to sponsor selected industry and trade events in the US and in St. Petersburg.


The Company intends to provide customer service and reservations centers in New York and in St. Petersburg, to list the Company's schedules and tariffs in the Official Airline Guide, and provide world-wide access to reservations on the Company’s flights through a major Computer Reservations and Ticketing System (“CRS”).


The Company intends to activate its reservations service when the DOT issues its order authorizing the Company to sell tickets.


The Company has identified the following market segments in the U.S.-Russia market: (i) Business Travelers, (ii) General Tourism, (iii) Ethnic Travelers, (iv) Special Interest Groups, (v) Professional Exchanges, and (vi) Government and Diplomatic Travel.


The Company believes that the direct non-stop service to be offered by it will be superior to the stop-over service currently offered by foreign airlines. A comparison between the two services with respect to passenger convenience and cargo transport efficiency is set forth below.


BALTIA - US flag, non-stop service: With non-stop service, a passenger can fly from JFK to St. Petersburg in about 8 hours in a Boeing B747 wide body airplane. Cargo arrives containerized, palletized, and secure.


Foreign, stop-over journeys: With stop-over service, it would take a passenger 10 to 18 hours to fly through Helsinki, Copenhagen, Moscow, or Frankfurt on a foreign carrier. In addition, passengers must change to narrow-body aircraft at a layover airport. Cargo is “broken up” and manually loaded onto narrow-body aircraft, or trucked from Helsinki.


The Company plans to operate efficiently and provide consistent high quality service to passengers and cargo shippers alike in order to establish the Company as the preferred airline in the market. The Company also plans to use targeted marketing of its service to maintain and grow its market share.


Because of the increased reliability and comfort of a non-stop flight, the Company expects to capture a portion of the existing traffic.


With the Boeing 747 true wide-body aircraft, the Company intends to provide cargo service from JFK to St. Petersburg, offering containers, pallets, and block space arrangements. The Company expects to carry contract cargo for express shippers. The Company also plans to market its own “Baltia Courier”, “Baltia Express”, and “Baltia Priority” express service for letters and packages. The Company also expects revenues from diplomatic mail and cargo, under the Fly America Act.


The Company has passenger service and ground service arrangements at JFK and at Pulkovo II Airport in St. Petersburg. As a US carrier flying into a foreign country, the Company will be eligible to the same degree of priority that a foreign carrier receives when arriving in the US.


The Company intends to start the JFK-St. Petersburg service with one round-trip flight per week, increase frequency to three round trips and then to five round trips per week.


The Company plans to build operating modules and apply them in developing new markets. Once established, the Company plans to duplicate its JFK-St. Petersburg standards on flights on other transatlantic routes.


Additional revenues from charter flying: In conjunction with its Part 121 air carrier certification (“Part 121”), (referring to a “Federal Aviation Regulations” number, is an industry acronym used to describe a US airline operating heavy jet aircraft) for scheduled service, the Company intends to seek certification for worldwide charter service. Following certification, the Company plans to utilize aircraft time available between scheduled service, to earn additional revenues from charters. We are also considering qualifying our aircraft for military contracts.


In order to start revenue generating flight operations, the Company has to complete FAA Air Carrier Certification. During the past two and half years, the Company has been participating in air carrier certification.


The Company will carry airline liability insurance as required for a US airline by DOT regulation.


As of March 31, 2013, the Company had a staff of thirty which includes professionals who have extensive major US airline experience in aircraft maintenance, airline operations, airline regulatory compliance, reservation, information technology, passenger service and administration.



March 31, 2013 Baltia Airlines 10-Q:


Baltia Air Lines Inc (BLTA) Stock Research Links

BLTA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Natural Field Reinvents Supplement Delivery at SupplySide

Updated Category News Views 0

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 106

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
Canton Fair: More Than Trade—A Cultural Exchange

Updated Category News Views 71

Why a Trade Fair Needs Lion Dances October 2026 marks a time when talking about a trade fair means diving headfirst into a whirlpool of global exchange and cultural tango we don’t often see in the West. Yeah, I'm looking at you, Canton Fair—a long-runner over in China that's managed to haul in the globe to not just showcase wares, but bring people together in a clash...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Elbit Systems Lands $200M APAC ISTAR Contracts

Updated Category News Views 38

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 119

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
Boscia's Future Ties Tradition and Modern Science

Updated Category News Views 74

Reviving a Skincare Legacy With the wind of innovation at its back, The Center Brands and Dr. Mamina Turegano are stepping in to breathe new life into Boscia. Now, I'm not just talking about a simple facelift. We're talking about an all-out integration of traditional Japanese skincare principles with the sharp edge of modern dermatologic science. It's a brave move...

Continue Reading
AVANT BIO Beef Up Team with Heavyweights Lio, Vanek

Updated Category News Views 95

AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...

Continue Reading
Redwood and SAP Partner on Secure File Transfer

Updated Category News Views 131

Redwood Advances SAP Interiors with New File Solution October 26, '26 is now a landmark for Redwood Software. They've just rolled out their SAP Managed File Transfer solution. Got the brainpower behind Redwood and SAP operating together here, and they're offering this to enterprises aimed at optimizing their file-based workflow. If you're scratching your head just hearing...

Continue Reading
Key Sewer Line Damage Signs Homeowners Often Ignore

Updated Category News Views 0

Spotting Trouble Beneath the Surface Now, when was the last time you eyeballed your home’s plumbing with more than a passing glance? Most folks don’t give their sewer lines two thoughts until something foul pops up. Plumbing expert Jessica Gerdeman from Heggemann, Inc. in Warrenton, Missouri, isn’t just blowing hot air when she points out the indicators of looming...

Continue Reading

Top 5 Most Recently Viewed Articles

DXC Technology to Announce Q3 Fiscal 2026 Earnings Soon

Updated Category News Views 159

DXC Technology Announces Upcoming Q3 Fiscal 2026 Earnings DXC Technology (NYSE: DXC), a prominent leader in enterprise technology and innovation, has set a date for the release of its financial results for the third quarter of fiscal 2026. The earnings report will be published on a Thursday, after the market closes, providing stakeholders with insights into the company's...

Continue Reading
Jim Cramer Highlights Mettler-Toledo as a Buy Amid Market Woes

Updated Category News Views 188

Jim Cramer Recommends Mettler-Toledo International Inc. On a recent episode of CNBC's popular program, Jim Cramer advised investors to consider buying shares of Mettler-Toledo International Inc. (NYSE: MTD). Cramer's endorsement came after the company reported impressive quarterly results, showcasing strong financial health. Strong Earnings Report from Mettler-Toledo...

Continue Reading
Strategic Alliance Between Vireo and Curio Enhances Growth Opportunities

Updated Category News Views 110

Strategic Partnership Announced Leading cannabis companies Vireo Growth Inc. and Curio Wellness have forged a partnership aimed at leveraging shared resources to tap into the burgeoning cannabis market. This collaboration marks an exciting new chapter for both companies as they work to introduce innovative health and wellness products to consumers. Vireo Growth Inc.: A...

Continue Reading
Anoto Group Reports Second Quarter Results 2024

Updated Category News Views 137

Overview of the Interim Report for 2024 The interim report covering January to June 2024 provides important insights into Anoto Group AB's operations and financial health. Anoto Group continues to be a leader in technology, particularly in optical recognition and digital writing. This report emphasizes key financial metrics and the company's strategic initiatives in a...

Continue Reading
AAOS: Orthobiologics' Future Anchored in Solid Science

Updated Category News Views 9

The Challenge of Orthobiologics: Hype vs. Science Amid the buzz around orthobiologics, it's high time folks face reality: enthusiasm doesn't equal evidence. Dr. Jason Dragoo, the symposium co-chair, hit the nail right on the head—the medical community's chief duty is to sift the wheat from the chaff when it comes to flashy new treatments that lack scientific backing....

Continue Reading